Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q58670645 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241221010728.0 | ||
| 008 | 241221nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q58670645 | ||
| 024 | ‡a 0000-0001-5109-2062 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q58670645 | ||
| 100 | 0 | ‡a Marco Matos ‡c researcher ORCID ID = 0000-0001-5109-2062 ‡9 en | |
| 375 | ‡a 1 ‡2 iso5218 | ||
| 400 | 0 | ‡a Marco Matos ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes. | ||
| 670 | ‡a Author's Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades | ||
| 670 | ‡a Author's Antagonistic interaction between adenosine A2A receptors and Na+/K+-ATPase-α2 controlling glutamate uptake in astrocytes | ||
| 670 | ‡a Author's Astrocytes detect and upregulate transmission at inhibitory synapses of somatostatin interneurons onto pyramidal cells | ||
| 670 | ‡a Author's Astrocytic adenosine A2A receptors control the amyloid-β peptide-induced decrease of glutamate uptake | ||
| 670 | ‡a Author's Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: relevance to schizophrenia | ||
| 670 | ‡a Author's Ecto-5'-nucleotidase (CD73)-mediated formation of adenosine is critical for the striatal adenosine A2A receptor functions | ||
| 670 | ‡a Author's Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer's disease | ||
| 670 | ‡a Author's Oncostatin M promotes excitotoxicity by inhibiting glutamate uptake in astrocytes: implications in HIV-associated neurotoxicity | ||
| 909 | ‡a (orcid) 0000000151092062 ‡9 1 | ||
| 919 | ‡a ecto5nucleotidasecd73mediatedformationofadenosineiscriticalforthestriataladenosinea2areceptorfunctions ‡A Ecto-5'-nucleotidase (CD73)-mediated formation of adenosine is critical for the striatal adenosine A2A receptor functions ‡9 1 | ||
| 919 | ‡a astrocyticadenosinea2areceptorscontroltheamyloidβpeptideinduceddecreaseofglutamateuptake ‡A Astrocytic adenosine A2A receptors control the amyloid-β peptide-induced decrease of glutamate uptake ‡9 1 | ||
| 919 | ‡a astrocytesdetectandupregulatetransmissionatinhibitorysynapsesofsomatostatininterneuronsontopyramidalcells ‡A Astrocytes detect and upregulate transmission at inhibitory synapses of somatostatin interneurons onto pyramidal cells ‡9 1 | ||
| 919 | ‡a antagonisticinteractionbetweenadenosinea2areceptorsandna+k+atpaseα2controllingglutamateuptakeinastrocytes ‡A Antagonistic interaction between adenosine A2A receptors and Na+/K+-ATPase-α2 controlling glutamate uptake in astrocytes ‡9 1 | ||
| 919 | ‡a amyloidbetapeptidedecreasesglutamateuptakeinculturedastrocytesinvolvementofoxidativestressandmitogenactivatedproteinkinasecascades ‡A Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades ‡9 1 | ||
| 919 | ‡a adenosinea2areceptorsmodulateglutamateuptakeinculturedastrocytesandgliosomes ‡A Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes. ‡9 1 | ||
| 919 | ‡a deletionofadenosinea2areceptorsfromastrocytesdisruptsglutamatehomeostasisleadingtopsychomotorandcognitiveimpairmentrelevancetoschizophrenia ‡A Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: relevance to schizophrenia ‡9 1 | ||
| 919 | ‡a oncostatin1000promotesexcitotoxicitybyinhibitingglutamateuptakeinastrocytesimplicationsinhivassociatedneurotoxicity ‡A Oncostatin M promotes excitotoxicity by inhibiting glutamate uptake in astrocytes: implications in HIV-associated neurotoxicity ‡9 1 | ||
| 919 | ‡a modulationofastrocytereactivityimprovesfunctionaldeficitsinmousemodelsofalzheimersdisease ‡A Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer's disease ‡9 1 | ||
| 946 | ‡a b ‡9 1 | ||
| 996 | ‡2 BLBNB|001587135 | ||
| 996 | ‡2 LC|n 2023253565 | ||
| 996 | ‡2 PLWABN|9810604862805606 | ||
| 996 | ‡2 LC|n 2012213522 | ||
| 996 | ‡2 BLBNB|000470719 | ||
| 996 | ‡2 ISNI|0000000069519661 | ||
| 996 | ‡2 LC|no2009171893 | ||
| 996 | ‡2 BLBNB|000291459 | ||
| 996 | ‡2 DNB|1236582772 | ||
| 996 | ‡2 PTBNP|328686 | ||
| 996 | ‡2 BLBNB|000318940 | ||
| 996 | ‡2 ISNI|0000000070337283 | ||
| 996 | ‡2 ISNI|0000000073205059 | ||
| 996 | ‡2 PTBNP|946803 | ||
| 996 | ‡2 DE633|pe30101057 | ||
| 996 | ‡2 NTA|073331074 | ||
| 996 | ‡2 ISNI|0000000071543142 | ||
| 996 | ‡2 PTBNP|29645 | ||
| 996 | ‡2 BLBNB|000236352 | ||
| 996 | ‡2 LC|n 2019250712 | ||
| 996 | ‡2 PTBNP|266033 | ||
| 996 | ‡2 ISNI|0000000070329275 | ||
| 996 | ‡2 BLBNB|001071856 | ||
| 996 | ‡2 BIBSYS|5073418 | ||
| 996 | ‡2 BLBNB|001494208 | ||
| 996 | ‡2 DNB|1259635740 | ||
| 996 | ‡2 ISNI|0000000109307066 | ||
| 996 | ‡2 ISNI|0000000069119588 | ||
| 996 | ‡2 DNB|1072865351 | ||
| 996 | ‡2 LC|nb2009005106 | ||
| 996 | ‡2 NTA|418887454 | ||
| 996 | ‡2 NUKAT|n 2017033105 | ||
| 996 | ‡2 SUDOC|070959900 | ||
| 996 | ‡2 DNB|1244261904 | ||
| 996 | ‡2 ISNI|0000000055600709 | ||
| 996 | ‡2 LC|no2003028140 | ||
| 996 | ‡2 PTBNP|788485 | ||
| 996 | ‡2 PTBNP|1197051 | ||
| 996 | ‡2 ISNI|0000000040326268 | ||
| 996 | ‡2 LC|n 2017251050 | ||
| 996 | ‡2 BNF|12906486 | ||
| 996 | ‡2 BLBNB|001439208 | ||
| 996 | ‡2 BLBNB|001458879 | ||
| 996 | ‡2 BLBNB|000545867 | ||
| 996 | ‡2 PTBNP|1393969 | ||
| 996 | ‡2 NUKAT|n 2011062369 | ||
| 996 | ‡2 LC|n 2005204258 | ||
| 996 | ‡2 ISNI|0000000048127116 | ||
| 996 | ‡2 DNB|127152830 | ||
| 996 | ‡2 DNB|1207580767 | ||
| 996 | ‡2 BLBNB|000291456 | ||
| 996 | ‡2 PTBNP|152344 | ||
| 996 | ‡2 PTBNP|1426933 | ||
| 996 | ‡2 LC|no2010046936 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
